ADMINISTRATION OF A BISPECIFIC CONSTRUCTION BINDING TO CD33 AND CD3 INTENDED FOR USE IN A TREATMENT PROCESS FOR MYELOID LEUKEMIA

MA44726AUndetermined Publication Date: 2019-02-27AMGEN RESEARCH (MUNICH) GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA44726
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-04-19
Filing Date
2017-04-18
Publication Date
2019-02-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.